acquisistion in pharma Archives • NCK Pharma

Aurobindo Pharma acquires Veritaz Healthcare

Posted on31 Mar 2022

Tagsacquisistion in pharma, acquisition, Aurobindo, Veritaz Healthcare

Comments0

Aurobindo Pharma Ltd has announced the acquisition of the domestic formulation business of Veritaz Healthcare for a consideration of Rs. 171 crore...

Pharma aaquisition: Aurobindo to acquire dermatology and oral solids businesses from Sandoz Inc. for $900 million

Posted on06 Sep 2018

Tagsacquisistion in pharma, acquisition in pharma, acquisition of injectable business, global pharma deals, global pharma licensing deal

Comments0

Aurobindo Pharma’s US based subsidiary Aurobindo Pharma USA Inc has entered into a definitive agreement with Sandoz Inc., USA, a Novartis division,...

Case Study: Allergan’s $2.48 billion acquisition Zeltiq Aesthetics

Posted on13 Feb 2017

Tagsacquisistion in pharma, Allergan, Allergan -An Actavis company, ZELTIQ, Zeltiq Aesthetics

Comments0

Botox maker Allergan Plc agrees to acquire body-contouring product maker Zeltiq Aesthetics Inc for about $2.48 billion, adding muscle to its line-up...

Intas Pharma to acquire Teva’s UK, Ireland generics businesses

Posted on11 Oct 2016

Tagsacquisistion in pharma, Cipla, Intas Pharma

Comments0

Intas Pharmaceuticals Ltd agreed to buy Actavis UK Ltd and Actavis Ireland Ltd from Israeli generic drug maker Teva Pharmaceutical Industries Ltd...

Marina Biotech to acquire ketamine program from Turing Pharmaceuticals

Posted on08 May 2016

Tagsacquisistion in pharma, Marina Biotech, Turing Pharmaceuticals

Comments0

USA-based Marina Biotech, a nucleic acid-based drug discovery company, and privately-held Swiss firm Turing Pharmaceuticals have executed a term sheet under which...